Global antibody production market to reach $13.28 bn by 2021

August 26, 2016 | Friday | Features | By BioSpectrum Bureau

Global antibody production market to reach $13.28 bn by 2021

(Photo Courtesy: www.amgenscience.com)

(Photo Courtesy: www.amgenscience.com)

The improved approval rate of therapeutic antibodies by regulatory authorities, patent expiry of blockbuster monoclonal antibodies, increasing adoption of targeted immunotherapy, and increased R&D expenditure of pharmaceutical and biotechnology companies are driving the overall antibody production market.

The increasing prevalence of infectious diseases and rising demand for protein therapeutics are expected to provide growth opportunities for players operating in this market.

Based on end users, the market is segmented into pharmaceutical and biotechnology companies, research institutes, and diagnostic laboratories.

See Also: India's medical devices market will hit $17.6 bn by 2020

The pharmaceutical and biotechnology companies segment is expected account for the largest share of the antibody production market and is estimated to register the highest CAGR.

 

The large number of drug development procedures to meet the shortened industry timelines is driving significant investments by companies towards research and development activities; this is a key market driver for this end-user segment.

The prominent players in the antibody production market include GE Healthcare (US), Thermo Fisher Scientific (US), Sartorius (Germany), Merck KGaA (Germany), Pall (US), Sigma-Aldrich (Germany), Eppendorf AG (Germany), Cellab (Germany), INTEGRA Biosciences (Switzerland), and FiberCell Systems (US).

 

Comments

× Your session has expired. Please click here to Sign-in or Sign-up

Have an Account?

Forgot your password?

First Name should not be empty!

Last Name should not be empty!

Email address should not be empty!

Show Password should not be empty!

Show Confirm Password should not be empty!

Newsletter

E-magazine

Biospectrum Infomercial

Bio Resource

I accept the terms & conditions & Privacy policy